PharmaAConsultancy ApS: Financial statements 2025
CVR: 42788341
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PharmaAConsultancy ApS (CVR 42788341) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 59,301 and a net result of DKK -81,144 compared with DKK -119,168 the year before. That is a decrease of 87.9% compared with the year before. The profit margin was -136.8%. Equity in the 2025 report amounted to DKK 7,542. The solvency ratio was 15.8%.
- Revenue
- DKK 59,301
- Gross Profit
- DKK 14,561
- Profit/Loss
- DKK -81,144
- Equity
- DKK 7,542
- Total Assets
- DKK 47,624
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 59K | 15K | -81K | 8K | - |
| 2024 | 488K | 297K | -119K | 89K | - |
| 2023 | 220K | 178K | 136K | 208K | - |
Official annual report
How creditworthy is PharmaAConsultancy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PharmaAConsultancy ApS has published its annual report for 2024. Revenue came to DKK 488,332, and the net result was DKK -119,168.
About PharmaAConsultancy ApS
PharmaAConsultancy ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2021. The company is registered under the industry Anden undervisning i.a.n.. The management consists of Hashmatullah Nasimi and Khalid Essam Abdel-Raouf Amar. The company is owned by Khalid Essam Abdel-Raouf Amar and Hashmatullah Nasimi. The company has 2 employees (2025). In 2025, the company reported revenue of DKK 59,301 and a net result of DKK -81,144 compared with DKK -119,168 the year before. Equity in the 2025 report amounted to DKK 7,542.